Menu Search
Equities

Walgreens Boots Alliance Inc

W8A:BRN

Walgreens Boots Alliance Inc

Actions
  • Price (CHF)30.64
  • Today's Change0.00 / 0.00%
  • Shares traded6.62k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Mar 10 2023.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The Company's U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in AmerisourceBergen. Its International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. Its portfolio of consumer brands include Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Its U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.

  • Revenue in USD (TTM)132.18bn
  • Net income in USD-2.96bn
  • Incorporated2014
  • Employees200.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		WBA:NSQ since
announced		Transaction
value
CareCentrix IncAnnounced11 Oct 202211 Oct 2022Announced4.24%392.00m
Data delayed at least 15 minutes, as of Mar 20 2023 20:00 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.